drugset / Trial / NCT02699086
A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
Non-randomizedSequentialOpen-labelTreatment
Summary
The primary objective of this trial was to determine the effective doses and treatment period of PDC-1421 Capsule in subjects with ADHD. The secondary objective was to evaluate the safety of PDC-1421 Capsule in subjects receiving PDC-1421 at various dose levels.
Timeline
- Start
- 2019-12-01
- Primary completion
- 2020-07-15
- Completion
- 2020-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PDC-1421 | Unknown | 1 unknown | Oral |
| Subject | PDC-1421 | Unknown | 2 unknown | Oral |